Back
ACADIA Pharmaceuticals Vs. Supernus Pharmaceuticals Industry Stock Comparison
Sell
28
ACAD
ACADIA Pharmaceuticals
Last Price:
16.43
Seasonality Move:
0.51%
Sell
29
SUPN
Supernus Pharmaceuticals
Last Price:
32.11
Seasonality Move:
-9.35%
Sell
28
ACADIA Pharmaceuticals (ACAD)
is a Sell
Is ACADIA Pharmaceuticals a Buy, Sell or Hold?
- The current ACADIA Pharmaceuticals [ACAD] share price is $16.44. The Score for ACAD is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- ACAD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy, Sell or Hold?
- The current Supernus Pharmaceuticals [SUPN] share price is $32.12. The Score for SUPN is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- SUPN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACAD Stock Price Chart
What is ACADIA Pharmaceuticals's stock price today?
-
The ACADIA Pharmaceuticals share price today is $16.44
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACAD is experiencing selling pressure, which indicates risk of future bearish movement.
SUPN Stock Price Chart
What is Supernus Pharmaceuticals's stock price today?
-
The Supernus Pharmaceuticals share price today is $32.12
The current trend is relatively stagnant and SUPN is experiencing slight buying pressure.
ACAD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 52.87 | Buy |
Chaikin Money Flow: | -301211 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.66 - 16.36) | Buy |
Bollinger Bands (100): | (15.03 - 17.49) | Buy |
SUPN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.21 | Sell |
Relative Strength Index (14 RSI): | 45.86 | Sell |
Chaikin Money Flow: | 72355 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.23 - 35.11) | Sell |
Bollinger Bands (100): | (27.01 - 32.71) | Buy |
ACAD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.13 | Buy |
20-day SMA: | 16.11 | Buy |
50-day SMA: | 16.86 | Sell |
200-day SMA: | 19.98 | Sell |
8-day EMA: | 16.23 | Buy |
20-day EMA: | 16.2 | Buy |
50-day EMA: | 16.41 | Buy |
200-day EMA: | 18.69 | Sell |
SUPN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.72 | Buy |
20-day SMA: | 33.48 | Sell |
50-day SMA: | 31.92 | Buy |
200-day SMA: | 29.77 | Buy |
8-day EMA: | 32.09 | Buy |
20-day EMA: | 32.66 | Sell |
50-day EMA: | 31.9 | Buy |
200-day EMA: | 30.35 | Buy |
ACADIA Pharmaceuticals Earnings Growth & ACAD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.56 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.88 per share, and an increase next year of $0.31 per share.
Supernus Pharmaceuticals Earnings Growth & SUPN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.18 per share.
ACADIA Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Supernus Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |